<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03560362</url>
  </required_header>
  <id_info>
    <org_study_id>15-03838</org_study_id>
    <nct_id>NCT03560362</nct_id>
  </id_info>
  <brief_title>Postoperative Pain Control With Lipossomic Extended Release Bupivacaine</brief_title>
  <official_title>Randomized Trial Comparing Bupivacaine vs Lipossomic Extended Release Bupivacaine for Postoperative Pain Control After Minimally Invasive Thoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tennessee Health Science Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Tennessee Health Science Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized trial of intraoperative intercostal block with bupivacaine with epinephrine
      compared to lipossomal extended release bupivacaine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing minimally invasive thoracic surgery will be randomized to receive 0.05%
      bupivacaine with 1:200,000 epinephrine (control group) or extended release lipossomal
      bupivacaine. Primary outcomes are postoperative pain measured by visual analog scale, amount
      of morphine equivalent narcotics used, and postoperative complications. Patients are excluded
      if they undergo open thoracotomy, or minimally invasive decortication.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 9, 2015</start_date>
  <completion_date type="Anticipated">October 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>3-5 days post op</time_frame>
    <description>Pain assessment with Visual Analog Scale (VAS). This is a numeric pain scale widely used in healthcare that ranks pain from 0 (no pain) to 10 (unbearable pain). A pain score below 3 is considered good.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>90 days post op</time_frame>
    <description>Any complication occuring in the first 90 days classified according to the Clavien-Dindo classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Narcotic used</measure>
    <time_frame>3-5 days post op</time_frame>
    <description>Amount of morphine equivalent dosage used in the postoperative period</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Bupivacaine with epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive intraoperative intercostal nerve block with bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lipossomal extended release bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive intraoperative intercostal nerve block with lipossomal extended release bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine liposome</intervention_name>
    <arm_group_label>Lipossomal extended release bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine / Epinephrine</intervention_name>
    <arm_group_label>Bupivacaine with epinephrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients who will be undergoing minimally invasive thoracic surgery

          -  Patients who will be undergoing minimally invasive thoracic surgery

        Exclusion Criteria:

          -  Open surgery

          -  Chronic use of narcotics

          -  Use of pregabalin or similar

          -  Significant liver or kidney dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benny Weksler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tennessee Health Science Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benny Weksler, MD</last_name>
    <phone>901-448-2918</phone>
    <email>bweksler@uthsc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Suzie Glass, RN</last_name>
    <phone>901-448-2918</phone>
    <email>Suzie.Glass@mlh.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Methodist University Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benny Weksler</last_name>
      <phone>901-448-2918</phone>
      <email>bweksler@uthsc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 6, 2018</study_first_submitted>
  <study_first_submitted_qc>June 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2018</study_first_posted>
  <last_update_submitted>June 18, 2018</last_update_submitted>
  <last_update_submitted_qc>June 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Tennessee Health Science Center</investigator_affiliation>
    <investigator_full_name>Benny Weksler</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>bupivacaine</keyword>
  <keyword>lipossomal extended release bupivacaine</keyword>
  <keyword>Intercostal nerve block</keyword>
  <keyword>thoracic surgery</keyword>
  <keyword>minimally invasive surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

